Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mandeli

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|October 11, 2008
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cellsJ Altomonte, L Wu, M Meseck, et al.
Gynecologic Oncology|March 1, 1995
A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancerJ L Speyer, J Mandeli, H Hochster, et al.
ISRN Radiology|June 27, 2014
Digital breast tomosynthesis changes management in patients seen at a tertiary care breast centerL Margolies, A Cohen, E Sonnenblick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology GroupS Wadler, H Haynes, J J Beitler, et al.
Journal of Clinical Gastroenterology|April 1, 1993
Survival after combined modality therapy for pancreatic cancerH W Bruckner, S Kalnicki, J Dalton, et al.
Current Opinion in Oncology|February 13, 1999
PSC833: initial clinical results in refractory ovarian cancer patientsA Fields, H Hochster, C Runowicz, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infectionJ D Jiang, F N Chu, P H Naylor, et al.
Cancer|April 15, 1997
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology GroupS Wadler, E L Schwartz, H Haynes, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|October 11, 2008
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cellsJ Altomonte, L Wu, M Meseck, et al.
Gynecologic Oncology|March 1, 1995
A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancerJ L Speyer, J Mandeli, H Hochster, et al.
ISRN Radiology|June 27, 2014
Digital breast tomosynthesis changes management in patients seen at a tertiary care breast centerL Margolies, A Cohen, E Sonnenblick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology GroupS Wadler, H Haynes, J J Beitler, et al.
Journal of Clinical Gastroenterology|April 1, 1993
Survival after combined modality therapy for pancreatic cancerH W Bruckner, S Kalnicki, J Dalton, et al.
Current Opinion in Oncology|February 13, 1999
PSC833: initial clinical results in refractory ovarian cancer patientsA Fields, H Hochster, C Runowicz, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infectionJ D Jiang, F N Chu, P H Naylor, et al.
Cancer|April 15, 1997
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology GroupS Wadler, E L Schwartz, H Haynes, et al.
Pageof 6